TE_22951
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1P1_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 166.01 |
| Counts of samples | TCGA_tumor:1030; TCGA_normal:2; GTEx:4 |
| TSS | chr11(-):45128453 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_22951.21 | - | Intergenic | Non-coding | Non-coding | chr11(-):45107300,45107320,45111178,45111212,45111406,45111511,45128401,45128454 |
| teRNA_22951.22 | - | Intergenic | Non-coding | Non-coding | chr11(-):45107300,45107320,45111021,45111212,45111406,45111471,45128401,45128454 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
